ADMA Biologics | Sustainability Performance
This company develops and commercializes specialty plasma-derived biologics, focusing on therapeutic treatments for immunodeficient patients. It operates in the biopharmaceutical sector, emphasizing patient needs.
2004
United States
501 - 1,000 employees
Biotechnology
$500M - 1B in revenue
$100M - 500M in profitability
Submit or report inaccurate dataDownload Company InsightsⓘBy downloading this report, you'll receive the most insightful and detailed analysis of the company's sustainability performance, compared to its peers. It includes key industry trends, carbon and energy intensity, nature impact, social metrics, and an in-depth look at key risks and controversies.
Sustainability Ranking & Industry Benchmark
#7337
Overallⓘ#1595
in United Statesⓘ#162
in BiotechnologyⓘSustainability Maturity
ⓘSustainability Intent
ⓘOverview
Environmental
Digital emissionsFinancial Data
Business performanceCapital & innovationAnalyst projectionsControversy level
Powered by illuminem
Sustainability employees
ⓘWe follow the strictest rules to ensure compliance with all the relevant data protection laws, including GDPR. Click here for our Privacy Policy.Total sustainability employees
4-6
ⓘThis value represents the estimated number of employees in a company with sustainability-related roles or job titles, as determined by Illuminem using publicly available data.